Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3.05x is 73% above its 5-year average of -11.19x, around the middle of its 5-year range (-435.56x–579.00x).
102.78% below its 12-month average of 109.77x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 579.00x.
INTEREST COVERAGE RATIO
-3.05x
INTEREST COVERAGE RATIO AVG TTM
109.77x
INTEREST COVERAGE RATIO AVG 3Y
-3.36x
INTEREST COVERAGE RATIO AVG 5Y
-11.19x
INTEREST COVERAGE RATIO AVG 10Y
-19.11x
INTEREST COVERAGE RATIO AVG 15Y
-19.11x
INTEREST COVERAGE RATIO AVG 20Y
-19.11x
CURRENT VS TTM AVG
-102.78%
CURRENT VS 3Y AVG
+9.29%
CURRENT VS 5Y AVG
+72.73%
CURRENT VS 10Y AVG
+84.04%
CURRENT VS 15Y AVG
+84.04%
CURRENT VS 20Y AVG
+84.04%
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 448 covered companies
CURRENT VS SECTOR MEDIAN
+44.95%
vs the sector median at left
Fennec Pharmaceuticals Inc.
Market Cap
$356.58M
Interest Coverage Ratio
-3.05x
TTM Avg
109.77x
3Y Avg
-3.36x
5Y Avg
-11.19x
Market Cap
$355.92M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.28M
Interest Coverage Ratio
3.07x
TTM Avg
2.31x
3Y Avg
3.74x
5Y Avg
3.74x
Market Cap
$355.18M
Interest Coverage Ratio
-11.11x
TTM Avg
316.78x
3Y Avg
4209.35x
5Y Avg
3030.57x
Market Cap
$355.58M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$362.81M
Interest Coverage Ratio
-12.13x
TTM Avg
372.18x
3Y Avg
320.22x
5Y Avg
320.22x
Market Cap
$364.53M
Interest Coverage Ratio
-26.33x
TTM Avg
2025.11x
3Y Avg
2025.11x
5Y Avg
2025.11x
Market Cap
$352.10M
Interest Coverage Ratio
-45.13x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$374.87M
Interest Coverage Ratio
-1.91x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fennec Pharmaceuticals Inc. (FENC) | $356.58M | -3.05x | 109.77x | -3.36x | -11.19x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.92M | N/A | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $357.28M | 3.07x | 2.31x | 3.74x | 3.74x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $355.18M | -11.11x | 316.78x | 4209.35x | 3030.57x |
| Relmada Therapeutics, Inc. (RLMD)vs › | $355.58M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $362.81M | -12.13x | 372.18x | 320.22x | 320.22x |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | -26.33x | 2025.11x | 2025.11x | 2025.11x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $352.10M | -45.13x | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $374.87M | -1.91x | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $376.04M | N/A | 4.06x | 4.06x | 4.06x |
Interest Coverage
-3.0x
Debt/Equity
0.00
Current Ratio
5.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 579.00x |
| 2026-03-31 | -17.00x |
| 2025-12-31 | -8.38x |
| 2025-09-30 | -0.34x |
| 2025-06-30 | -4.43x |
| 2025-03-31 | -1.36x |
| 2024-12-31 | -0.99x |
| 2024-09-30 | -5.10x |
| 2024-06-30 | -4.72x |
| 2024-03-31 | 13.29x |
| 2023-12-31 | -1.99x |
| 2023-09-30 | -1.19x |
| 2023-06-30 | -5.13x |
| 2023-03-31 | -6.60x |
| 2022-12-31 | -7.53x |
| 2022-09-30 | -66.38x |
| 2022-06-30 | -88.63x |
| 2022-03-31 | -61.14x |
| 2021-09-30 | -76.39x |
| 2021-06-30 | -435.56x |
| 2019-06-30 | -283.12x |
| 2019-03-31 | -223.33x |
| 2014-03-31 | -268.50x |
| 2013-06-30 | -309.00x |
| 2004-12-31 | -19.75x |
